CLOSE X

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE14652.50207.95 (+1.44 %)
PREV CLOSE ( ) 14444.55
OPEN PRICE ( ) 14550.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 765
TODAY'S LOW / HIGH ( )14522.00 14810.20
52 WK LOW / HIGH ( )10598.05 19748.4
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director
Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
29Apr Neuland Laboratories submits earnings
Neuland Laboratories has informed that the company will announce its res..
14Apr Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
14Apr Neuland Laboratories informs about pre
Neuland Laboratories has informed that it enclosed copies of newspaper a..
11Mar Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
04Feb Neuland Laboratories informs about ana
Neuland Laboratories has informed that the Company’s management will be..
Financials
Rs. in Millions
QTR Dec 25 ANNUAL 25
Net Profit404.172594.26
Gross Profit 542.72 3453.74
Operating Profit 849.793428.08
Net Sales 4397.0914768.37
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi Cons. Health (BSE)
 4799.15 (2.66%)
M.Cap ( in Cr)11052.74
Emcure Pharma (BSE)
 1732.85 (7.69%)
M.Cap ( in Cr)32853.02
Abbott India (BSE)
 25484.55 (0.47%)
M.Cap ( in Cr)54152.89
Divi's Lab (BSE)
 6535.00 (1.57%)
M.Cap ( in Cr)173483.72
Concord Biotech (BSE)
 1131.90 (5.68%)
M.Cap ( in Cr)11841.51
Shareholding Pattern
PROMOTERS 32.63%
NON-INSTITUTION 31.07%
MUTUAL FUNDS/UTI 11.35%
FI/BANKS/INSURANCE 1.3%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data February 2026 Broking Complaints Data February 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.